TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,775 | +19.7% | 1,278,300 | +21.6% | 0.04% | +19.4% |
| Q2 2023 | $16,520 | -1.4% | 1,051,546 | +3.4% | 0.04% | -5.3% |
| Q1 2023 | $16,758 | -39.8% | 1,016,855 | -43.0% | 0.04% | -47.2% |
| Q4 2022 | $27,849 | -99.9% | 1,785,206 | -4.1% | 0.07% | 0.0% |
| Q3 2022 | $24,150,000 | -13.6% | 1,862,022 | -6.4% | 0.07% | -2.7% |
| Q2 2022 | $27,936,000 | +73.1% | 1,989,772 | +76.5% | 0.07% | +124.2% |
| Q1 2022 | $16,143,000 | +2.6% | 1,127,270 | -2.3% | 0.03% | -8.3% |
| Q4 2021 | $15,730,000 | +10.0% | 1,154,076 | +32.2% | 0.04% | 0.0% |
| Q3 2021 | $14,294,000 | +36.3% | 872,651 | +40.1% | 0.04% | +44.0% |
| Q2 2021 | $10,485,000 | +2.0% | 622,965 | +10.7% | 0.02% | -10.7% |
| Q1 2021 | $10,276,000 | -6.9% | 562,734 | -7.3% | 0.03% | -12.5% |
| Q4 2020 | $11,043,000 | -47.4% | 606,778 | -48.5% | 0.03% | -3.0% |
| Q3 2020 | $21,004,000 | +4.4% | 1,177,396 | +5.0% | 0.03% | -5.7% |
| Q2 2020 | $20,112,000 | +171.4% | 1,121,718 | +129.8% | 0.04% | -7.9% |
| Q1 2020 | $7,410,000 | -15.2% | 488,111 | +10.2% | 0.04% | +11.8% |
| Q4 2019 | $8,743,000 | +36.3% | 443,112 | +18.8% | 0.03% | +13.3% |
| Q3 2019 | $6,415,000 | -17.5% | 372,972 | -15.1% | 0.03% | -18.9% |
| Q2 2019 | $7,776,000 | -6.6% | 439,339 | +7.5% | 0.04% | -9.8% |
| Q1 2019 | $8,323,000 | – | 408,588 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |